RecruitingNCT07668804
A Study to Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy
PHASE1 · PHASE2 · 31 planned enrolment
- Countries listed
- 1
- Registry update
- June 25, 2026
Registry Intervention View
sham injection
Trial registrations containing the exact intervention label sham injection.
Exact registry label · Not reported
8 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
5 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT04744662
ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration
PHASE1 · 28 planned enrolment
- Countries listed
- 2
- Registry update
- November 19, 2024
CompletedNCT02358889
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
PHASE2 · 88 planned enrolment
- Countries listed
- 1
- Registry update
- September 24, 2020
CompletedNCT01397409
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
PHASE2 · 271 planned enrolment
- Countries listed
- 8
- Registry update
- April 16, 2019
CompletedNCT01414153
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
PHASE2 · 158 planned enrolment
- Countries listed
- 1
- Registry update
- October 17, 2016
TerminatedNCT01319188
Ranibizumab and the Risk of Arterial Thromboembolic Events
PHASE4 · 380 planned enrolment
- Countries listed
- 2
- Registry update
- May 19, 2015
CompletedNCT00913744
Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion
PHASE2 · 100 planned enrolment
- Countries listed
- 6
- Registry update
- December 17, 2014
TerminatedNCT01603043
A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
PHASE2 · 10 planned enrolment
- Countries listed
- 0
- Registry update
- January 20, 2014